{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T04:00:16Z","timestamp":1760241616705,"version":"build-2065373602"},"reference-count":52,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2018,6,2]],"date-time":"2018-06-02T00:00:00Z","timestamp":1527897600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100011541","name":"Division of Cancer Epidemiology and Genetics, National Cancer Institute","doi-asserted-by":"publisher","award":["Contracts HHSN261201100063C and HHSN261201100007I"],"award-info":[{"award-number":["Contracts HHSN261201100063C and HHSN261201100007I"]}],"id":[{"id":"10.13039\/100011541","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000038","name":"U.S. Food and Drug Administration","doi-asserted-by":"publisher","award":["PUR4763663"],"award-info":[{"award-number":["PUR4763663"]}],"id":[{"id":"10.13039\/100000038","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Epstein-Barr virus (EBV) is linked to several cancers, including endemic Burkitt lymphoma (eBL), but causal variants are unknown. We recently reported novel sequence variants in the LMP-1 gene and promoter in EBV genomes sequenced from 13 of 14 BL biopsies. Alignments of the novel sequence variants for 114 published EBV genomes, including 27 from BL cases, revealed four LMP-1 variant patterns, designated A to D. Pattern A variant was found in 48% of BL EBV genomes. Here, we used PCR-Sanger sequencing to evaluate 50 additional BL biopsies from Ghana, Brazil, and Argentina, and peripheral blood samples from 113 eBL cases and 115 controls in Uganda. Pattern A was found in 60.9% of 64 BL biopsies evaluated. Compared to PCR-negative subjects in Uganda, detection of Pattern A in peripheral blood was associated with eBL case status (odds ratio [OR] 31.7, 95% confidence interval: 6.8\u2013149), controlling for relevant confounders. Variant Pattern A and Pattern D were associated with eBL case status, but with lower ORs (9.7 and 13.6, respectively). Our results support the hypothesis that EBV LMP-1 Pattern A may be associated with eBL, but it is not the sole associated variant. Further research is needed to replicate and elucidate our findings.<\/jats:p>","DOI":"10.3390\/cancers10060177","type":"journal-article","created":{"date-parts":[[2018,6,4]],"date-time":"2018-06-04T08:40:39Z","timestamp":1528101639000},"page":"177","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Frequency of EBV LMP-1 Promoter and Coding Variations in Burkitt Lymphoma Samples in Africa and South America and Peripheral Blood in Uganda"],"prefix":"10.3390","volume":"10","author":[{"given":"Hsiao-Mei","family":"Liao","sequence":"first","affiliation":[{"name":"Center for Biologics Evaluation and Research, Food and Drug Administration, White Oak, MD 20993, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hebing","family":"Liu","sequence":"additional","affiliation":[{"name":"Center for Biologics Evaluation and Research, Food and Drug Administration, White Oak, MD 20993, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heiyan","family":"Lei","sequence":"additional","affiliation":[{"name":"Center for Biologics Evaluation and Research, Food and Drug Administration, White Oak, MD 20993, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bingjie","family":"Li","sequence":"additional","affiliation":[{"name":"Center for Biologics Evaluation and Research, Food and Drug Administration, White Oak, MD 20993, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pei-Ju","family":"Chin","sequence":"additional","affiliation":[{"name":"Center for Biologics Evaluation and Research, Food and Drug Administration, White Oak, MD 20993, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shien","family":"Tsai","sequence":"additional","affiliation":[{"name":"Center for Biologics Evaluation and Research, Food and Drug Administration, White Oak, MD 20993, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kishor","family":"Bhatia","sequence":"additional","affiliation":[{"name":"Cancer Genetics, Inc., Rutherford, NJ 07070, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marina","family":"Gutierrez","sequence":"additional","affiliation":[{"name":"Laboratorio Stamboulian, Laboratorio Stamboulian, Buenos Aires 1414, Argentina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sidnei","family":"Epelman","sequence":"additional","affiliation":[{"name":"Department of Pediatric Oncology, St Marcelina Hospital, Sao Paolo 08270-070, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert J.","family":"Biggar","sequence":"additional","affiliation":[{"name":"Infections and Immunoepidemiology Branch, National Cancer Institute, Bethesda, MD 20892, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francis","family":"Nkrumah","sequence":"additional","affiliation":[{"name":"Noguchi Memorial Institute, Kor Le Bu University, P.O. Box LG 581 Legon, Accra, Ghana"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janet","family":"Neequaye","sequence":"additional","affiliation":[{"name":"Department of Child Health, University of Ghana, P.O. Box LG 25 Legon, Accra, Ghana"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin D.","family":"Ogwang","sequence":"additional","affiliation":[{"name":"EMBLEM Study, St. Mary\u2019s Hospital, Lacor, P.O. Box 180, Gulu, Uganda"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven J.","family":"Reynolds","sequence":"additional","affiliation":[{"name":"Division of Intramural Research, National Institute of Allergy and Infectious Diseases, Bethesda, MD 20892, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shyh-Ching","family":"Lo","sequence":"additional","affiliation":[{"name":"Center for Biologics Evaluation and Research, Food and Drug Administration, White Oak, MD 20993, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8273-9831","authenticated-orcid":false,"given":"Sam M.","family":"Mbulaiteye","sequence":"additional","affiliation":[{"name":"Infections and Immunoepidemiology Branch, National Cancer Institute, Bethesda, MD 20892, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2018,6,2]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1038\/2281056a0","article-title":"EBV DNA in biopsies of Burkitt tumours and anaplastic carcinomas of the nasopharynx","volume":"228","author":"Klein","year":"1970","journal-title":"Nature"},{"key":"ref_2","first-page":"349","article-title":"Nasopharyngeal carcinoma (NPC). VI. Presence of an EBV nuclear antigen in fresh tumour biopsies. Preliminary results","volume":"19","author":"Ablashi","year":"1973","journal-title":"Biomedicine"},{"key":"ref_3","unstructured":"(1997). Proceedings of the IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Epstein-Barr Virus and Kaposi\u2019s Sarcoma Herpesvirus\/Human Herpesvirus 8. Lyon, France, 17\u201324 June 1997. IARC Monogr. Eval. Carcinog. Risks Hum., 70, 1\u2013492."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1002\/(SICI)1097-0142(19960515)77:10<2137::AID-CNCR27>3.0.CO;2-V","article-title":"Nasal T-cell lymphoma causally associated with Epstein-Barr virus: Clinicopathologic, phenotypic, and genotypic studies","volume":"77","author":"Harabuchi","year":"1996","journal-title":"Cancer"},{"key":"ref_5","first-page":"661","article-title":"Clonal Epstein-Barr virus in lymphoepithelioma-like carcinoma of the stomach: Demonstration of viral genome by in situ hybridization and southern blot analysis","volume":"5","author":"Pittaluga","year":"1992","journal-title":"Mod. Pathol."},{"key":"ref_6","first-page":"213","article-title":"Epstein-Barr virus-associated gastric adenocarcinoma among Japanese Americans in Hawaii","volume":"2","author":"Shibata","year":"1993","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S1470-2045(08)70175-X","article-title":"Part I: Cancer in Indigenous Africans\u2014burden, distribution, and trends","volume":"9","author":"Parkin","year":"2008","journal-title":"Lancet Oncol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/35095584","article-title":"Epstein-Barr virus: Exploiting the immune system","volume":"1","year":"2001","journal-title":"Nat. Rev. Immunol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"e609","DOI":"10.1016\/S2214-109X(16)30143-7","article-title":"Global burden of cancers attributable to infections in 2012: A synthetic analysis","volume":"4","author":"Plummer","year":"2016","journal-title":"Lancet Glob. Health"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.virusres.2009.07.005","article-title":"The extent of genetic diversity of Epstein-Barr virus and its geographic and disease patterns: A need for reappraisal","volume":"143","author":"Chang","year":"2009","journal-title":"Virus Res."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1056\/NEJM198109243051305","article-title":"Burkitt\u2019s lymphoma","volume":"305","author":"Ziegler","year":"1981","journal-title":"N. Engl. J. Med."},{"key":"ref_12","first-page":"177","article-title":"Variation in the sequence of Epstein Barr virus nuclear antigen 1 in normal peripheral blood lymphocytes and in Burkitt\u2019s lymphomas","volume":"13","author":"Bhatia","year":"1996","journal-title":"Oncogene"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"4084","DOI":"10.1128\/jvi.64.9.4084-4092.1990","article-title":"Epstein-Barr virus types 1 and 2 differ in their EBNA-3A, EBNA-3B, and EBNA-3C genes","volume":"64","author":"Sample","year":"1990","journal-title":"J. Virol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"156","DOI":"10.3390\/pathogens1020156","article-title":"Epstein-Barr virus sequence variation-biology and disease","volume":"1","author":"Tzellos","year":"2012","journal-title":"Pathogens"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"e00375-17","DOI":"10.1128\/JVI.00375-17","article-title":"Natural variation of Epstein-Barr virus genes, proteins, and primary microrna","volume":"91","author":"Correia","year":"2017","journal-title":"J. Virol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1002\/ijc.24223","article-title":"Epstein-Barr virus and the pathogenesis of Burkitt\u2019s lymphoma: More questions than answers","volume":"124","author":"Bornkamm","year":"2009","journal-title":"Int. J. Cancer"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Kwok, H., and Chiang, A.K. (2016). From conventional to next generation sequencing of Epstein-Barr virus genomes. Viruses, 8.","DOI":"10.3390\/v8030060"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"16706","DOI":"10.1038\/srep16706","article-title":"Epstein-Barr virus from Burkitt lymphoma biopsies from Africa and South America share novel LMP-1 promoter and gene variations","volume":"5","author":"Lei","year":"2015","journal-title":"Sci. Rep."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"107fs7","DOI":"10.1126\/scitranslmed.3002878","article-title":"Epstein-Barr virus: An important vaccine target for cancer prevention","volume":"3","author":"Cohen","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"ref_20","first-page":"58","article-title":"Evaluating the causal link between malaria infection and endemic Burkitt lymphoma in Northern Uganda: A Mendelian Randomization study","volume":"25","author":"Legason","year":"2017","journal-title":"EBio Medicine"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/s12936-017-1778-z","article-title":"Age and geographic patterns of plasmodium falciparum malaria infection in a representative sample of children living in Burkitt lymphoma-endemic areas of Northern Uganda","volume":"16","author":"Maziarz","year":"2017","journal-title":"Malar. J."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s11262-007-0153-5","article-title":"The vIL-10 gene of the Epstein-Barr virus (EBV) is conserved in a stable manner except for a few point mutations in various EBV isolates","volume":"35","author":"Kanai","year":"2007","journal-title":"Virus Genes"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1099\/0022-1317-72-10-2399","article-title":"Isolation and sequencing of the Epstein-Barr virus BNLF-1 gene (LMP1) from a Chinese nasopharyngeal carcinoma","volume":"72","author":"Hu","year":"1991","journal-title":"J. Gen. Virol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.1099\/0022-1317-75-10-2729","article-title":"Sequence variation in the Epstein-Barr virus latent membrane protein 1","volume":"75","author":"Miller","year":"1994","journal-title":"J. Gen. Virol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1006\/viro.1999.9855","article-title":"Signature amino acid changes in latent membrane protein 1 distinguish Epstein-Barr virus strains","volume":"261","author":"Edwards","year":"1999","journal-title":"Virology"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1086\/314672","article-title":"The molecular epidemiology and evolution of Epstein-Barr virus: Sequence variation and genetic recombination in the latent membrane protein-1 gene","volume":"179","author":"Walling","year":"1999","journal-title":"J. Infect. Dis."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1136\/mp.53.5.280","article-title":"Analysis of the Epstein-Barr virus (EBV) latent membrane protein 1 (LMP-1) gene and promoter in hodgkin\u2019s disease isolates: Selection against EBV variants with mutations in the LMP-1 promoter ATF-1\/CREB-1 binding site","volume":"53","author":"Sandvej","year":"2000","journal-title":"Mol. Pathol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1023\/A:1008265304712","article-title":"Intraclonal molecular heterogeneity suggests a hierarchy of pathogenetic events in Burkitt\u2019s lymphoma","volume":"8","author":"Gutierrez","year":"1997","journal-title":"Ann. Oncol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1086\/499277","article-title":"High levels of Epstein-Barr virus DNA in saliva and peripheral blood from Ugandan mother-child pairs","volume":"193","author":"Mbulaiteye","year":"2006","journal-title":"J. Infect. Dis."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/ijc.2910220304","article-title":"Primary Epstein-Barr virus infections in African infants. I. Decline of maternal antibodies and time of infection","volume":"22","author":"Biggar","year":"1978","journal-title":"Int. J. Cancer"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"13105","DOI":"10.1038\/s41598-017-12994-0","article-title":"Virus and host-specific differences in oral human herpesvirus shedding kinetics among Ugandan women and children","volume":"7","author":"Matrajt","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/1047-2797(90)90020-S","article-title":"Viruses and cancer. Causal associations","volume":"1","author":"Evans","year":"1990","journal-title":"Ann. Epidemiol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1056\/NEJMoa021641","article-title":"Epidemiologic classification of human papillomavirus types associated with cervical cancer","volume":"348","author":"Munoz","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/0140-6736(91)90203-2","article-title":"Circulating Epstein-Barr virus-carrying B cells in acute malaria","volume":"337","author":"Lam","year":"1991","journal-title":"Lancet"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Smatti, M.K., Yassine, H.M., AbuOdeh, R., AlMarawani, A., Taleb, S.A., Althani, A.A., and Nasrallah, G.K. (2017). Prevalence and molecular profiling of Epstein Barr virus (EBV) among healthy blood donors from different nationalities in Qatar. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0189033"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Gantuz, M., Lorenzetti, M.A., Chabay, P.A., and Preciado, M.V. (2017). A novel recombinant variant of latent membrane protein 1 from Epstein Barr virus in Argentina denotes phylogeographical association. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0174221"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"8696","DOI":"10.1073\/pnas.1504447112","article-title":"Origin and dynamics of admixture in Brazilians and its effect on the pattern of deleterious mutations","volume":"112","author":"Kehdy","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"4884","DOI":"10.1128\/jvi.70.8.4884-4894.1996","article-title":"Frequency of multiple Epstein-Barr virus infections in T-cell-immunocompromised individuals","volume":"70","author":"Yao","year":"1996","journal-title":"J. Virol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"6546","DOI":"10.1128\/JVI.77.11.6546-6550.2003","article-title":"Multiple Epstein-Barr virus infections in healthy individuals","volume":"77","author":"Walling","year":"2003","journal-title":"J. Virol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1182\/blood.V92.2.600.414k33_600_606","article-title":"Epstein-Barr virus in nasal lymphomas contains multiple ongoing mutations in the EBNA-1 gene","volume":"92","author":"Gutierrez","year":"1998","journal-title":"Blood"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1056\/NEJMra032015","article-title":"Persistence of the Epstein-Barr virus and the origins of associated lymphomas","volume":"350","author":"Gross","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1182\/blood-2007-10-117655","article-title":"LMP1 signaling can replace CD40 signaling in B cells in vivo and has unique features of inducing class-switch recombination to IgG1","volume":"111","author":"Rastelli","year":"2008","journal-title":"Blood"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1126\/science.286.5438.300","article-title":"Mimicry of CD40 signals by Epstein-Barr virus LMP1 in B lymphocyte responses","volume":"286","author":"Uchida","year":"1999","journal-title":"Science"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"9150","DOI":"10.1073\/pnas.90.19.9150","article-title":"Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation","volume":"90","author":"Kaye","year":"1993","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1073\/pnas.94.4.1447","article-title":"The Epstein-Barr virus lmp1 amino acid sequence that engages tumor necrosis factor receptor associated factors is critical for primary B lymphocyte growth transformation","volume":"94","author":"Izumi","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"12592","DOI":"10.1073\/pnas.94.23.12592","article-title":"The Epstein-Barr virus oncogene product latent membrane protein 1 engages the tumor necrosis factor receptor-associated death domain protein to mediate B lymphocyte growth transformation and activate NF-kappaB","volume":"94","author":"Izumi","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"9041","DOI":"10.1128\/JVI.00541-13","article-title":"Autocrine CCL3 and CCL4 induced by the oncoprotein LMP1 promote Epstein-Barr virus-triggered B cell proliferation","volume":"87","author":"Tsai","year":"2013","journal-title":"J. Virol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"4380","DOI":"10.1128\/JVI.06966-11","article-title":"The latent membrane protein 1 (LMP1) oncogene of Epstein-Barr virus can simultaneously induce and inhibit apoptosis in B cells","volume":"86","author":"Pratt","year":"2012","journal-title":"J. Virol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.semcancer.2008.10.004","article-title":"Multiple roles of LMP1 in Epstein-Barr virus induced immune escape","volume":"18","author":"Middeldorp","year":"2008","journal-title":"Semin. Cancer Biol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"3261","DOI":"10.1182\/blood.V79.12.3261.3261","article-title":"Molecular epidemiology of Burkitt\u2019s lymphoma from South America: Differences in breakpoint location and Epstein-Barr virus association from tumors in other world regions","volume":"79","author":"Gutierrez","year":"1992","journal-title":"Blood"},{"key":"ref_51","unstructured":"Nkrumah, F.K. (1984). Changes in the presentation of Burkitt\u2019s lymphoma in Ghana over a 15-year period (1969\u20131982). IARC Sci. Publ., 665\u2013674."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1093\/jnci\/57.5.1051","article-title":"Burkitt\u2019s lymphoma: Its clinical course in relation to immunologic reactivities to Epstein-Barr virus and tumor-related antigens","volume":"57","author":"Nkrumah","year":"1976","journal-title":"J. Natl. Cancer Inst."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/10\/6\/177\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T15:07:02Z","timestamp":1760195222000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/10\/6\/177"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,2]]},"references-count":52,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2018,6]]}},"alternative-id":["cancers10060177"],"URL":"https:\/\/doi.org\/10.3390\/cancers10060177","relation":{},"ISSN":["2072-6694"],"issn-type":[{"type":"electronic","value":"2072-6694"}],"subject":[],"published":{"date-parts":[[2018,6,2]]}}}